ResearchMoz

Global Gynecological Cancers Market 2014-2018

Technavio
Published Date » 2013-12-20
No. Of Pages » 55

TechNavio's analysts forecast the Global Gynecological Cancers market to grow at a CAGR of 12.47 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in prevalence of gynecological cancer. The Global Gynecological Cancers market has also been witnessing the emergence of personalized medicines. However, the increase in use of CAM could pose a challenge to the growth of this market. 

TechNavio's report, the Global Gynecological Cancers Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Gynecological Cancers market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this space are Becton Dickinson and Co., Bristol Myers Squibb Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., and GlaxoSmithKline plc.

Other vendor mentioned in the report is Merck & Co.

Key questions answered in this report: 

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
Table of Content

1. Executive Summary

2. List of Abbreviations

3. Scope of the Report
3.1 Market Overview
3.2 Product Offerings

4. Market Research Methodology
4.1 Market Research Process
4.2 Research Methodology

5. Introduction

6. Market Landscape
6.1 Market Overview
6.2 Market Size and Forecast
6.3 Global Ovarian Cancers Market
6.3.1 Market Size and Forecast
6.4 Global Cervical Cancers Market
6.4.1 Market Size and Forecast
6.5 Global Uterine Cancer Market
6.5.1 Market Size and Forecast
6.6 Five Forces Analysis

7. Geographical Segmentation

8. Buying Criteria

9. Market Growth Drivers

10. Drivers and their Impact

11. Market Challenges

12. Impact of Drivers and Challenges

13. Market Trends

14. Trends and their Impact

15. Vendor Landscape
15.1 Competitive Scenario
15.1.1 Key News
15.1.2 Mergers and Acquisitions
15.2 Market Share Analysis 2013
15.3 Other Prominent Vendors

16. Key Vendor Analysis
16.1 Becton, Dickinson and Co.
16.1.1 Business Overview
16.1.2 Business Segmentation
16.1.3 Key Information
16.1.4 SWOT Analysis
16.2 Bristol Myers Squibb Co.
16.2.1 Business Overview
16.2.2 Key Information
16.2.3 SWOT Analysis
16.3 Eli Lilly and Co.
16.3.1 Business Overview
16.3.2 Key Information
16.3.3 SWOT Analysis
16.4 F. Hoffmann La Roche Ltd.
16.4.1 Business Overview
16.4.2 Business Segmentation
16.4.3 Key Information
16.4.4 SWOT Analysis
16.5 GlaxoSmithKline plc
16.5.1 Business Overview
16.5.2 Business Segmentation
16.5.3 Key Information
16.5.4 SWOT Analysis

17. Other Reports in this Series

List of Tables

NA

List of Figures


Exhibit 1: Market Research Methodology
Exhibit 2: Global Gynecological Cancers Market 2013-2018 (US$ billion)
Exhibit 3: Global Ovarian Cancers Market 2013-2018 (US$ billion)
Exhibit 4: Global Cervical Cancers Market 2013-2018 (US$ billion)
Exhibit 5: Global Uterine Cancer Market 2013-2018 (US$ billion)
Exhibit 6: Global Gynecological Cancers Market by Geographical Segmentation 2013
Exhibit 7: Business Segmentation of Becton, Dickinson and Co.
Exhibit 8: Business Segmentation of F. Hoffmann La Roche Ltd.
Exhibit 9: Business Segmentation of GlaxoSmithKline plc.

Upcoming Reports:

Disinfectant Equipments Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
By - Transparency Market Research
The developing economies provide a significantly large pool for under-served patients, thus representing big opportunities for the leading medical equipment manufacturers. China is the world’s most populated country and home to largest patient base. There are around 120 million people aged 65 and above in need of continuous medical care.  India is the second largest country in terms of population and serves as home to 1.2 billion people. As world population continues to grow, there is a growing demand for healthcare services and disinfectant equipments. Disinfectant...
Wireless High Definition (HD) Market - Global Industry Analysis, Market Size, Share, Growth, Trends and Forecast, 2012 - 2018
By - Transparency Market Research
The global wireless HD market has shown remarkable progress in the recent years and is also showing good market potential in the future. A wireless HD is used in many applications such as in medicine, industrial processes, and consumer electronics. Some of the recent applications of wireless HD are portable media players and portable gaming devices, HD camcorders, and 3G/4G mobile communications handsets. The global wireless HD market is driven by factors such as emerging technological developments and increasing penetration in emerging economies. The launch of new...
Multi-Parameter Patient Monitoring Equipment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Multiparameter patient monitors are referred as monitoring systems that measure and display numerical data and waveforms for patient. These are parameters obtained through monitoring systems used for the diagnosis and treatment of patients in various healthcare departments. These monitoring devices are used to display signals of various vital signs such as respiratory rate, heart rate, temperature, ECG, blood pressure and others. These devices work by converting electrical signals into readable form that is shown on the monitors display. Global multiparameter patient...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Top End Stereo Systems Maker Harman Targets Chinese Auto Market
Apr 22, 2014  
Harman, the U.S.-based audio company that is best known as the provider of automobile stereos for top-end car models such as Mercedes-Benz, BMW and Ferrari, has said that it has signed agreements with two leading Chinese automakers—Chang’An and Geely. The company, that is associated with premium infotainment systems for leading auto makers, said that these new contracts...
Scientists Identify Cure for Dengue
Apr 18, 2014  
In a breakthrough discovery that can change the way dengue is treated, scientists have identified a drug target for the deadly dengue viruses. This discovery may help pave the way for discovery of vaccines that can cure this condition that affects nearly 390 million people throughout the world each year.  Scientists have used a new technique for this discovery to show that a region...
India is Facing a Cancer Crisis
Apr 15, 2014  
India is currently facing a cancer crisis – reports a recent research carried out at the King’s college London, in collaboration with the Tata Memorial Cancer Centre, Mumbai.  The reasons estimated for this crisis comprise of increasing rates of smoking, unequal access to proper treatment and belated diagnosis.  Every year, India witnesses around one...
Microparticle Tags to Check Counterfeit Goods Invented
Apr 14, 2014  
Researchers from the Massachusetts Institute of Technology have invented a new set of microparticles that can easily be read by smartphones and establish the authenticity of currency, electronic items and luxury goods.  This strategy is among those countless measures taken by big brands and companies to label their legitimate products in order to stop illegal copies of the...
USFDA Approves Lupins Generic Diabetic Drug
Apr 10, 2014  
The United States Food and Drugs Administration (USFDA) has finally approved Lupin Pharmaceuticals Inc (LPI), the American subsidiary of Indian drug manufacturers Lupin Ltd, to sell Pioglitazone Tablets in the U.S market. The approval has been granted first for fiscal 2015.  Pioglitazone is a generic medicine used for managing diabetes and is a version of Actos tablets...